MXPA04005053A - Metodos y composiciones para tratar lesiones del epitelio respiratorio. - Google Patents

Metodos y composiciones para tratar lesiones del epitelio respiratorio.

Info

Publication number
MXPA04005053A
MXPA04005053A MXPA04005053A MXPA04005053A MXPA04005053A MX PA04005053 A MXPA04005053 A MX PA04005053A MX PA04005053 A MXPA04005053 A MX PA04005053A MX PA04005053 A MXPA04005053 A MX PA04005053A MX PA04005053 A MXPA04005053 A MX PA04005053A
Authority
MX
Mexico
Prior art keywords
methods
compositions
treating lesions
respiratory epithelium
lesions
Prior art date
Application number
MXPA04005053A
Other languages
English (en)
Inventor
K Podolsky Daniel
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of MXPA04005053A publication Critical patent/MXPA04005053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invencion se refiere a metodos de tratar lesiones del epitelios de las vias respiratorias por administracion local o sistemica de peptidos trifolios intestinales. El peptido trifolio intestinal puede ser administrado ya sea solo o en combinacion con uno o mas agentes terapeuticos.
MXPA04005053A 2001-11-28 2002-11-27 Metodos y composiciones para tratar lesiones del epitelio respiratorio. MXPA04005053A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33383601P 2001-11-28 2001-11-28
PCT/US2002/038258 WO2003045332A2 (en) 2001-11-28 2002-11-27 Methods and compositions for treating lesions of the respiratory epithelium

Publications (1)

Publication Number Publication Date
MXPA04005053A true MXPA04005053A (es) 2004-09-10

Family

ID=23304463

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005053A MXPA04005053A (es) 2001-11-28 2002-11-27 Metodos y composiciones para tratar lesiones del epitelio respiratorio.

Country Status (8)

Country Link
US (2) US20030114384A1 (es)
EP (1) EP1461076A4 (es)
JP (1) JP2005532988A (es)
CN (1) CN1617739A (es)
AU (1) AU2002351181B2 (es)
CA (1) CA2468344A1 (es)
MX (1) MXPA04005053A (es)
WO (1) WO2003045332A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US6610043B1 (en) 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US7654998B1 (en) 1999-08-23 2010-02-02 Aeris Therapeutics, Inc. Tissue volume reduction
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US7538082B2 (en) 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
MXPA04003267A (es) * 2001-10-05 2004-07-08 Gen Hospital Corp Metodos y composiciones para tratar lesiones dermicas.
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
CN1652795A (zh) * 2002-03-11 2005-08-10 埃里斯医疗公司 治疗肺气肿的组合物及方法
CN1655675A (zh) * 2002-03-26 2005-08-17 综合医院公司 利用三叶肽的联合治疗
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
EP1587534A1 (en) * 2003-01-17 2005-10-26 Children's Hospital Medical Center Use of tff2, or agents inducing tff2, in the therapy of allergies
EP1742625A1 (en) * 2004-04-05 2007-01-17 Sepracor, Inc. (r,r)-formoterol in combination with other pharmacological agents
US8075771B2 (en) * 2005-02-17 2011-12-13 E. I. Du Pont De Nemours And Company Apparatus for magnetic field gradient enhanced centrifugation
EP2091551B1 (en) * 2006-11-03 2020-01-15 Alba Therapeutics Corporation Method of treating asthma
ES2435197T3 (es) * 2007-01-10 2013-12-16 Board Of Regents, The University Of Texas System Administración mejorada de composiciones de fármacos inmunosupresores para la administración por vía pulmonar
WO2009006246A1 (en) * 2007-06-29 2009-01-08 Alea Therapeutics Corp. Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
DK2320911T3 (da) * 2008-08-01 2014-11-03 Eye Therapies Llc Vasokonstriktionspræparater og fremgangsmåder til anvendelse deraf
AU2011260713A1 (en) * 2010-06-04 2013-01-10 Trifoilium Aps Trefoil factors (TFF) for the treatment of chronic pulmonary diseases
CN105582526B (zh) * 2016-02-25 2020-07-17 山东睿鹰制药集团有限公司 三叶因子2在制备治疗及预防肺/支气管急性炎症疾病药物方面的应用
WO2021195883A1 (zh) * 2020-03-30 2021-10-07 山东睿鹰制药集团有限公司 TFF2蛋白和IFN-κ蛋白联用在治疗新型冠状病毒感染中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
US4370317A (en) * 1980-09-10 1983-01-25 Novo Industri A/S Pancreatic spasmolytic polypeptide
WO1992014837A1 (en) * 1991-02-14 1992-09-03 The General Hospital Corporation Intestinal trefoil proteins
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US6063755A (en) * 1991-02-14 2000-05-16 The General Hospital Corporation Intestinal trefoil proteins
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
US6426404B1 (en) * 1997-08-25 2002-07-30 The General Hospital Corporation Receptor for intestinal trefoil factor
NZ527232A (en) * 1998-08-26 2005-03-24 Smithkline Beecham Corp A composition contaning a PDE 4 inhibitor and a beta adrenergic bronchodilator useful for treating pulmonary diseases
US6372439B2 (en) * 1998-10-01 2002-04-16 James R. Goldenring Screen for gastric adenocarcinoma
WO2001046475A1 (en) * 1999-12-23 2001-06-28 Human Genome Sciences, Inc. Trefoil domain-containing polynucleotides, polypeptides, and antibodies
JP2004515235A (ja) * 2000-12-08 2004-05-27 ノボ ノルディスク アクティーゼルスカブ Ｔｆｆペプチド
US20030166535A1 (en) * 2001-04-24 2003-09-04 Podolsky Daniel K. Methods and compositions for treating oral and esophageal lesions

Also Published As

Publication number Publication date
US20030114384A1 (en) 2003-06-19
JP2005532988A (ja) 2005-11-04
WO2003045332A2 (en) 2003-06-05
AU2002351181A1 (en) 2003-06-10
WO2003045332A3 (en) 2003-07-24
EP1461076A2 (en) 2004-09-29
EP1461076A4 (en) 2005-03-09
CN1617739A (zh) 2005-05-18
CA2468344A1 (en) 2003-06-05
AU2002351181B2 (en) 2008-08-07
US20080167230A1 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
MXPA04005053A (es) Metodos y composiciones para tratar lesiones del epitelio respiratorio.
MXPA03009772A (es) Metodos y composiciones para tratar lesiones orales y del esofago.
IL267381A (en) A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders
CY1118849T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
MXPA04005865A (es) Suministro de aminoglucosidos a los pulmones.
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
AP1763A (en) Pulmonary administration of chemically modified insulin
MY126768A (en) Combinations of formoterol and fluticasone propionate for asthma
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
WO2003082196A3 (en) Combination therapy using trefoil peptides
GB9806632D0 (en) Peptide factor
NZ516477A (en) Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
WO2003022205A3 (en) Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
MY117918A (en) Use of an h+, k+- atpase inhibitor in the treatment of nasal polyps
WO2002069979A3 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
MXPA04001912A (es) Aminobenzofenonas novedosas.
SE9902597D0 (sv) New use
WO2001028535A3 (en) Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate
MXPA02008870A (es) Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos.
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
AU3739500A (en) Protease resistant flint analogs
WO2004039961A3 (en) Trefoil domain-containing polypeptides and uses thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal